did not reduce all-cause mortality. When compared with infants receiving the animal-derived surfactants beractant and poractant alfa, infants receiving lucinactant were found to have similar rates of mortality and morbidity from respiratory distress syndrome. More analysis is needed before the findings from lucinactant studies can be generalized because of questions about early trial closure and limited statistical power. Moreover, the metabolic fate of lucinactant and its component chemicals and potential risks introduced by the requirement to convert the lucinactant gel into a liquid using a special warming cradle immediately before instillation need additional study '. 3 So that takes us back to where we started with the 'warming cradle' rather than the 'water bath'.
We read with great interest the recent editorial and the original article published in the May issue of the journal. 1,2 Dr Gadzinowski, even though realizing that the results of the article will be challenging to the neonatologists outside North America, asserts that 'Improvements in the survival of newborns on the threshold of viability contributes to improved Neonatal mortality rates (NMRs) on an international scale'. However, 98% of neonatal deaths occur in developing countries. NMR are the highest in the Sub-Saharan regions of western, middle and eastern Africa and South-Central Asia with rates between 42 and 49 per 1000 live births.
3 More than two-thirds of the causes of neonatal deaths in these countries are due to causes not attributable to prematurity, and an even much smaller proportion can be attributed to extreme prematurity. 4 For example, in India extremely low birth weight neonates contribute only 14.5% of neonatal deaths (3680), in live births at 18 network institutions across all regions of India. 5 Though, many of us are now saving very and extremely low birth weight preterm neonates in developing countries, the advancement of neonatal care is hampered by marked heterogeneity within and between states, rural and urban gaps and within urban differences. 6, 7 Social exclusion, caste, maternal literacy, negative parental attitudes arising from social environment, gender bias, ability to pay, and lack of basic prenatal, natal and postnatal care are the main determinants of newborn survival in developing countries. [7] [8] [9] [10] Global scientific communities have increasingly realized the importance of cost-effective interventions for reducing neonatal mortality in developing countries. 11 Sri Lanka is a shining example in South Asia with NMR of 11 per 1000 live births without hi-tech neonatal intensive care infrastructure.
3 In India also the effectiveness of community-and home-based neonatal care has been shown in field trials. 12 It is estimated that 16 low-cost effective interventions can save 0.59-1.08 million lives in South Asia and 0.45-0.8 million lives in sub-Saharan Africa. 13 It is important for developing countries like India to keep their focus on providing essential and level II newborn care (low-cost) services for the majority of population, which would have a far greater chance for improvement on newborn survival rather than getting swayed by providing high-tech services to few babies at thresholds of viability. 1 They bring an important point of view in relation to priorities of developing world. We wish to clarify our views.
P Garg and S Gogia
The data of Kamath et al. 2 reflect the survival pattern of developed countries, USA and Western Europe. Our editorial commented on the influence of increased survival at threshold of viability in developed and developing countries that are striving to provide modern neonatal care and support thereby pushing the limits of viability. This is an evolutionary phenomenon experienced even in the developed countries during the last 30 years of developments in neonatology. Therefore, we projected that with time increasing numbers of babies in this category will be saved even in developing countries. We certainly agree with Garg and Gogia that not all countries are evolving at the same rate. We believe that each regional health system has to set their priorities according to their needs and conditions. I am also a fervent believer in low-cost interventions wherever possible, especially, those that improve outcomes. Thank you for such an interesting comment.
